Press releases
- Photocure and Richard Wolf Enter into Agreement to Develop a High-Definition Flexible Blue Light Cystoscope for Global Commercialization
- Photocure Announces Mobile BLC Tower Initiative to Expand Access to Cysview in the U.S.
- Photocure ASA - Annual general meeting held
- Photocure ASA: Results for the first quarter of 2024
- Photocure Partner Asieris announces New Drug Application acceptance for regulatory review of Cevira in China
- Bladder Cancer: Long-Term Benefits of Blue Light Cystoscopy and Enhanced Detection with HD Technology Unveiled at AUA 2024
- Photocure ASA - Notice of the Annual General Meeting 23 May 2024
- Photocure ASA: Annual Report 2023
More ▼
Key statistics
As of last trade, Photocure ASA (PHOo:STO) traded at 55.80, 13.53% above the 52 week low of 49.15 set on Jul 31, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 55.80 |
---|---|
High | 55.80 |
Low | 55.80 |
Bid | -- |
Offer | -- |
Previous close | 55.80 |
Average volume | 500.00 |
---|---|
Shares outstanding | 27.12m |
Free float | 26.11m |
P/E (TTM) | 310.63 |
Market cap | 1.48bn NOK |
EPS (TTM) | 0.1755 NOK |
Data delayed at least 15 minutes, as of Jul 16 2024 17:00 BST.
More ▼